EMILY PETERSON: Open Payments
NPI 1306554209 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 44 payments from 17 companies in 2025. Trend: 2023 $99 · 2024 $44 · 2025 $1,056
Food & beverage: $972Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $131 |
| Gilead Sciences, Inc. | 5 | $115 |
| Janssen Biotech, Inc. | 1 | $84 |
| Ardelyx, Inc. | 3 | $84 |
| Ipsen Biopharmaceuticals, Inc | 2 | $49 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Deciphera Pharmaceuticals Inc. | 1 | $32 |
| QOL Medical, LLC | 1 | $30 |
Products named: SKYRIZI, LINZESS, ENTYVIO, TREMFYA, IBSRELA, IQIRVO, EOHILIA, VELSIPITY.
Industry payments across AZ — which companies pay providers there.
